Racial and ethnic disparities in metabolic dysfunction- associated steatotic liver disease outcomes: A call for culturally sensitive interventions: Editorial on "Differences in liver and mortality outcomes of nonalcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study"

被引：3
|
作者：
Bae, Jae Hyun [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, 101,Daehak Ro, Seoul 03080, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2024年 / 30卷 / 04期
关键词：
Ethnicity; Healthcare disparities; Non-alcoholic fatty liver disease; Racial groups; Social determinants of health; SUSCEPTIBILITY; PREVALENCE; SEVERITY; PNPLA3;
D O I：
10.3350/cmh.2024.0562
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] RACIAL AND ETHNIC DISPARITIES IN THE LONG-TERM INCIDENCE OF CIRRHOSIS IN A NATIONAL COHORT OF VETERANS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE
    Yeoh, Aaron
    Yang, Zeyuan
    Cheung, Ramsey
    Ahmed, Aijaz
    Do, Albert
    Wong, Robert
    GASTROENTEROLOGY, 2023, 164 (06) : S1 - S2
  • [42] Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study
    Wang, Jun-Wei
    Jin, Chun-Hua
    Ke, Jiang-Feng
    Ma, Yi-Lin
    Wang, Yu-Jie
    Lu, Jun-Xi
    Li, Mei-Fang
    Li, Lian-Xi
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [43] PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) HAVE SIMILAR CLINICAL, NON-INVASIVE TESTS ( NITS) AND PATIENT-REPORTED OUTCOMES (PROS) PROFILE
    Younossi, Zobair
    Yilmaz, Yusuf
    Yu, Ling-Lung
    Isakov, Vasily
    Fernandez, Marlen Ivon Castellanos
    Wong, Vincent
    Eguchi, Yuichiro
    Romero-Gomez, Manuel
    Duseja, Ajay
    Bugianesi, Elisabetta
    Chan, Wah Kheong
    Alswat, Khalid
    Hamid, Saeed
    Singal, Ashwani
    Fan, Jian-Gao
    Papatheodoridis, George
    Gordon, Stuart
    El-Kassas, Mohamed
    Younes, Ziad
    Roberts, Stuart
    Mendez-Sanchez, Nahum Nahum
    Keklikkiran, Caglayan
    Ahmed, Aijaz
    Lam, Brian
    Nader, Fatema
    Henry, Linda
    Stepanova, Maria
    Alqahtani, Saleh
    HEPATOLOGY, 2024, 80
  • [44] Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes
    Newton, Kimberly P.
    Jayasekera, Dulshan
    Blackford, Amanda L.
    Behling, Cynthia
    Wilson, Laura A.
    Fishbein, Mark H.
    Molleston, Jean P.
    Xanthakos, Stavra A.
    Vos, Miriam B.
    Schwimmer, Jeffrey B.
    NASH CRN
    HEPATOLOGY, 2025,
  • [45] Association between liver histology and long-term clinical outcomes in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease in Sweden: a real-world cohort study (BRIDGE-MASH)
    Shang, Ying
    Vessby, Johan
    Mangla, Kamal Kant
    de laguiche, Elisabeth
    Ekstedt, Mattias
    Hagstrom, Hannes
    JOURNAL OF HEPATOLOGY, 2024, 80 : S462 - S463
  • [46] Racial/Ethnic Disparities in Long-Term Risks of Cirrhosis Among US Veterans With Metabolic Dysfunction-Associated Fatty Liver Disease
    Yeoh, Aaron J.
    Yang, Zeyuan
    Cheung, Ramsey
    Wong, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S869 - S870
  • [47] Effectiveness of Polyene phosphatidylcholine in metabolic-associated fatty liver disease treatment : a real-world study in China
    Pan, Yi
    Xue, Feng
    Wang, Shanshan
    Gao, Shuangqing
    Wei, Lai
    JOURNAL OF HEPATOLOGY, 2024, 80 : S613 - S613
  • [48] Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study
    Ghusn, Wissam
    Fansa, Sima
    Anazco, Diego
    Tama, Elif
    Nicolalde, Bryan
    Gala, Khushboo
    Cifuentes, Lizeth
    De La Rosa, Alan
    Sacoto, Daniel
    Campos, Alejandro
    Feris, Fauzi
    Acosta, Andres
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1127 - S1128
  • [49] MORTALITY OUTCOMES IN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WITH NO ALCOHOL CONSUMPTION VS MODERATE ALCOHOL CONSUMPTION: A NATIONWIDE COHORT STUDY
    Aboona, Majd B.
    Danpanichkul, Pojsakorn
    Chen, Vincent L.
    Kim, Donghee
    Arab, Juan Pablo
    Wijarnpreecha, Karn
    GASTROENTEROLOGY, 2024, 166 (05) : S1650 - S1651
  • [50] LIVER AND NON-LIVER OUTCOMES OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) VERSUS MASLD WITH INCREASED ALCOHOL USE (METALD) STRATIFIED BY PRESENCE OF VIRAL HEPATITIS: A STUDY OF 850,156 REAL-WORLD PATIENTS IN THE US
    Nguyen, Vy H.
    Zhang, Xinrong
    Cheung, Ramsey
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2024, 166 (05) : S1655 - S1655
12345